Approval · Notice of Compliance 20709 · 2018
COMPONENT TE-H IMPLANTS: Notice of Compliance 20709
Issued April 9, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20709
- Date
- April 9, 2018
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative - Merger/Buyout
- Canadian reference product
- REVALOR-H (Hoechst Canada (1996) Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMPONENT TE-H IMPLANTS | 02244729 | Dormant |
Medicinal ingredients
- ESTRADIOL 14 MG per IMP
- TRENBOLONE ACETATE 140 MG per IMP